Related Experiment Videos
Methicillin-resistant Staphylococcus aureus: impact on dermatology practice.
1Department of Microbiology and Infectious Diseases, South Western Area Pathology Service, Liverpool, New South Wales, Australia. i.gosbell@unsw.edu.au
American Journal of Clinical Dermatology
|August 11, 2004
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern in healthcare and community settings. Effective control requires strict hygiene, while MRSA infection treatment presents challenges due to resistance, necessitating combination therapies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) has transitioned from a hospital-acquired pathogen to a common community-associated threat.
- MRSA acquisition risk factors include healthcare exposure, chronic conditions, and invasive procedures, though community strains often emerge without these.
- Staphylococci transmission occurs readily person-to-person and via environmental contamination.
Purpose of the Study:
- To review the epidemiology, transmission, and challenges in treating Methicillin-resistant Staphylococcus aureus (MRSA).
- To highlight infection control strategies and current therapeutic options for MRSA infections.
Main Methods:
- Literature review of MRSA epidemiology, risk factors, and treatment modalities.
- Analysis of infection control measures, including hand hygiene and environmental cleaning.
- Evaluation of topical and systemic treatment options, including challenges with antimicrobial resistance.
Main Results:
- MRSA is prevalent in both healthcare and community settings, with increasing incidence.
- Effective infection control hinges on patient isolation, environmental disinfection, and rigorous hand hygiene, with alcohol-based rubs enhancing compliance.
- Treatment of MRSA infections is complicated by resistance to topical agents like mupirocin and fusidic acid.
- Systemic treatment requires non-beta-lactam agents; monotherapy with quinolones, rifampin, or fusidic acid frequently leads to resistance.
- Combination therapy, particularly with rifampin, is often considered, though data is limited. Fourth-generation quinolones and linezolid are expensive but promising.
Conclusions:
- MRSA poses a significant and evolving public health challenge requiring multifaceted control strategies.
- Hand hygiene is paramount in preventing MRSA spread.
- Managing MRSA infections necessitates careful consideration of treatment options due to the high risk of resistance, favoring combination therapies over monotherapy.